By AuntMinnieEurope.com staff writers

November 6, 2019 -- The European Association of Nuclear Medicine (EANM) and the American Society of Nuclear Cardiology (ASNC) have released a "Cardiac Amyloidosis Practice Points" document.

The goal is to identify the critical components involved in performing technetium-99m (Tc-99m) 3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) or Tc-99m hydroxymethylene diphosphonate (HMDP) imaging to evaluate cardiac transthyretin amyloidosis, according to the organizations. The practice points can be downloaded on the EANM's website.


Copyright © 2019 AuntMinnieEurope.com
 

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: